Amplify to Liquidate Weight Loss Drug & Treatment ETF in December
Amplify ETFs has announced plans to liquidate its Amplify Weight Loss Drug & Treatment ETF following a November 10, 2026, decision by the fund's Board of…
Tuttle Capital Management has announced plans to close the Opportunistic Trader ETF (WZRD), with the fund scheduled to delist from the Cboe BZX Exchange on November 17, 2026, and liquidate on November 20, 2026. The ETF will stop accepting creation orders and cease exchange trading following the market close on November 17. Shareholders who remain invested through liquidation will receive a cash distribution reflecting the value of their holdings, less applicable liabilities and expenses. During the liquidation period, the fund may increase its cash holdings and deviate from its investment strategy as it unwinds positions. Investors should also be aware that the closure may trigger taxable events, while transaction costs and extraordinary liquidation expenses will be borne by the fund and its shareholders.
Source: Press Release
Amplify ETFs has announced plans to liquidate its Amplify Weight Loss Drug & Treatment ETF following a November 10, 2026, decision by the fund's Board of…
Gabelli ETFs Trust has announced plans to liquidate the Gabelli High Income ETF, with the closure scheduled for approximately December 11, 2026, following…
National Bank Investments (NBI) has announced plans to voluntarily delist the ETF Series of the NBI Target 2026 Investment Grade Bond Fund (NTGA) from the…
F/m Investments plans to close and liquidate the F/m Compoundr High Yield Bond ETF (CPHY) on or around December 4, 2026, following approval by The RBB Fund's…
More from United States